申请人:RHIZEN PHARMACEUTICALS SA
公开号:US20160297761A1
公开(公告)日:2016-10-13
The present disclosure provides compounds of formula (I) to (III) as glutaminase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders involving glutamine